skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Material Type:
Article
Add to My Research

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Annals of oncology, 2018-02, Vol.29 (2), p.405-417 [Peer Reviewed Journal]

2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017 ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx651 ;PMID: 29092024

Full text available

2
Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs
Material Type:
Article
Add to My Research

Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs

Oncogene, 2016-04, Vol.35 (14), p.1743-1749 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Apr 7, 2016 ;Macmillan Publishers Limited 2016. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/onc.2015.249 ;PMID: 26119941 ;CODEN: ONCNES

Full text available

3
The AURORA initiative for metastatic breast cancer
Material Type:
Article
Add to My Research

The AURORA initiative for metastatic breast cancer

British journal of cancer, 2014-11, Vol.111 (10), p.1881-1887 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Nov 11, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.341 ;PMID: 25225904 ;CODEN: BJCAAI

Full text available

4
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Material Type:
Article
Add to My Research

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

The New England journal of medicine, 2016-08, Vol.375 (8), p.717-729 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1602253 ;PMID: 27557300

Full text available

5
90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)
Material Type:
Article
Add to My Research

90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)

Annals of oncology, 2022-05, Vol.33, p.S162-S163 [Peer Reviewed Journal]

2022 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2022.03.105

Full text available

6
295P Climate change impact and sustainability: A survey of Breast International Group (BIG) members
Material Type:
Article
Add to My Research

295P Climate change impact and sustainability: A survey of Breast International Group (BIG) members

ESMO open, 2024-05, Vol.9 [Peer Reviewed Journal]

2024 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1016/j.esmoop.2024.103352

Full text available

7
ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer
Material Type:
Article
Add to My Research

ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer

Annals of oncology, 2019-10, Vol.30, p.v97 [Peer Reviewed Journal]

ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz240.112

Full text available

8
289TiP - ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer
Material Type:
Article
Add to My Research

289TiP - ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer

Annals of oncology, 2019-10, Vol.30, p.v97-v97 [Peer Reviewed Journal]

2019 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz240.112

Full text available

9
Abstract OT1-03-05: A phase III, randomized, open label, multicenter, controlled trial of niraparib versus physician's choice in previously- treated, HER2 negative, germline BRCA mutation-positive breast cancer patients. An EORTC-BIG intergroup study (BRAVO study)
Material Type:
Article
Add to My Research

Abstract OT1-03-05: A phase III, randomized, open label, multicenter, controlled trial of niraparib versus physician's choice in previously- treated, HER2 negative, germline BRCA mutation-positive breast cancer patients. An EORTC-BIG intergroup study (BRAVO study)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT1-03-05-OT1-03-05 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS15-OT1-03-05

Full text available

10
Abstract P6-11-16: PYTHIA: A phase II study of palbociclib plus fulvestrant versus placebo plus fulvestrant for pretreated patients with ER+/HER2- metastatic breast cancer
Material Type:
Article
Add to My Research

Abstract P6-11-16: PYTHIA: A phase II study of palbociclib plus fulvestrant versus placebo plus fulvestrant for pretreated patients with ER+/HER2- metastatic breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-11-16 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS16-P6-11-16

Full text available

11
Abstract OT3-05-08: PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer
Material Type:
Article
Add to My Research

Abstract OT3-05-08: PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT3-05-08-OT3-05-08 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS17-OT3-05-08

Full text available

12
Abstract OT3-05-02: ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early triple negative breast cancer
Material Type:
Article
Add to My Research

Abstract OT3-05-02: ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early triple negative breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT3-05-02-OT3-05-02 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS18-OT3-05-02

Full text available

13
PALLAS: PALbociclib CoLlaborative adjuvant study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer
Material Type:
Article
Add to My Research

PALLAS: PALbociclib CoLlaborative adjuvant study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer

Annals of oncology, 2017-09, Vol.28, p.v66-v66 [Peer Reviewed Journal]

2017 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx362.064

Full text available

14
Abstract P5-14-01: Chemotherapy randomization of the EORTC 10041/ BIG 3-04 MINDACT (microarray in node-negative and 1 to 3 positive lymph node disease may avoid chemotherapy) trial
Material Type:
Article
Add to My Research

Abstract P5-14-01: Chemotherapy randomization of the EORTC 10041/ BIG 3-04 MINDACT (microarray in node-negative and 1 to 3 positive lymph node disease may avoid chemotherapy) trial

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-14-01 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS16-P5-14-01

Full text available

15
Abstract PD7-12: Molecular subtyping of male breast cancer by the International male breast cancer program (IMBC): EORTC 10085/TBCRC 0-29/BIG 2-07/NABCG/BOOG 2009-04
Material Type:
Article
Add to My Research

Abstract PD7-12: Molecular subtyping of male breast cancer by the International male breast cancer program (IMBC): EORTC 10085/TBCRC 0-29/BIG 2-07/NABCG/BOOG 2009-04

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD7-12-PD7-12 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS17-PD7-12

Full text available

16
Abstract P5-23-01: Clinical and biological characterization of male breast cancer (BC) EORTC 10085/TBCRC 029/BOOG 2013-02/BIG 2-07: Baseline results from the prospective registry
Material Type:
Article
Add to My Research

Abstract P5-23-01: Clinical and biological characterization of male breast cancer (BC) EORTC 10085/TBCRC 029/BOOG 2013-02/BIG 2-07: Baseline results from the prospective registry

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-23-01 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS17-P5-23-01

Full text available

17
Abstract OT1-03-21: PALLAS: PAlbociclib Collaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with adjuvant endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer
Material Type:
Article
Add to My Research

Abstract OT1-03-21: PALLAS: PAlbociclib Collaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with adjuvant endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT1-03-21-OT1-03-21 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS15-OT1-03-21

Full text available

18
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Material Type:
Article
Add to My Research

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 1533-4406 ;EISSN: 1533-4406

Full text available

19
289TiPALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer
Material Type:
Article
Add to My Research

289TiPALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Peer Reviewed Journal]

European Society for Medical Oncology 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz240.112

Full text available

20
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Material Type:
Article
Add to My Research

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Annals of Oncology, 2018-02, Vol.29 (2), p.405-417

open access ;DOI: 10.1093/annonc/mdx651

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (19)

Refine My Results

Creation Date 

From To
  1. Before 2014  (1)
  2. 2014 To 2015  (1)
  3. 2016 To 2016  (5)
  4. 2017 To 2018  (8)
  5. After 2018  (6)
  6. More options open sub menu

Searching Remote Databases, Please Wait